Given the pivotal role of NF-κB-regulated gene products in cartilage degradation, inflammation, and apoptosis [21], inhibition of NF-κB shows promise in treating conditions such as RA or osteoarthritis (OA). The gene discussed is NFKB1; the disease is rheumatoid arthritis.